Jaguar Gene Therapy Revenue
Biotechnology Research • 
Lake Forest, Illinois, United States • 21-50 Employees
Jaguar Gene Therapy revenue & valuation
| Annual revenue | $3,000,000 |
| Revenue per employee | $72,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,600,000 |
| Total funding | No funding |
Key Contacts at Jaguar Gene Therapy
Joseph Nolan
President And Chief Executive Officer
Sandeep Dhall
Director - Preclinical/Clinical Programs
Erica Wellington
Senior Director Finance
Kathy Powell
Strategic Sourcing & Procurement, Associate Director
Brian Moy
Director, Scientific Communications And Publications
Michael Hughes
Senior Director - Research And Preclinical/Clinical Programs
Amanda Gharst
Director- Program Management And Clinical Supply Chain
Stephen Ollosi
Director, Molecular Biology
Company overview
| Headquarters | Lake Forest, Illinois, United States |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Gene Therapy, Severe Genetic Diseases |
| Founded | 2019 |
| Employees | 21-50 |
| Socials |
Jaguar Gene Therapy Email Formats
Jaguar Gene Therapy uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@jaguargenetherapy.com), used 82.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@jaguargenetherapy.com | 82.6% |
{first initial}{last name} | jdoe@jaguargenetherapy.com | 13% |
{first name} | john@jaguargenetherapy.com | 4.3% |
About Jaguar Gene Therapy
Jaguar Gene Therapy, LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases including those that impact sizeable patient populations. The company is made up of a proven team of experts with unparalleled CMC (Chemistry, Manufacturing and Controls), regulatory, clinical and commercial acumen who have first-hand experience in bringing novel gene therapy treatments to patients and their families. Committed to patient safety and product purity, Jaguar is rapidly advancing an initial pipeline of three programs targeting: 1) Type 1 galactosemia; 2) a genetic cause of autism spectrum disorder and Phelan-McDermid syndrome and other severe neurodevelopmental disorders with a SHANK3 mutation or deletion; and 3) Type 1 diabetes. The company continues to evaluate opportunities to expand its pipeline using the strength of the team and close relationships with numerous academic institutions.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Jaguar Gene Therapy has 14 employees across 8 departments.
Departments
Number of employees
Jaguar Gene Therapy Tech Stack
Discover the technologies and tools that power Jaguar Gene Therapy's digital infrastructure, from frameworks to analytics platforms.
Video players
Form builders
JavaScript libraries
JavaScript libraries
Miscellaneous
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Miscellaneous
JavaScript libraries
Programming languages
Italy
Australia
Frequently asked questions
4.8
40,000 users
